NASDAQ:ENTX

Entera Bio Stock Insider Trading

Healthcare > Biotechnology

Buy ENTX

*Your capital is at risk

$1.22

-0.0300 (-2.40%)

At Close: Jun 03, 2026

Entera Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 8.52M and sold 0 ENTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	8.52M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 16, 2025 Buy	Stock Option (right to buy) A-Award	Yaacov-garbeli Dana Chief Financial Officer	C-Suite Officer	130 000 Value: $296.4K
Jul 16, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Yaacov-garbeli Dana Chief Financial Officer	C-Suite Officer	26 316 Value: $53.7K
Jul 16, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Yaacov-garbeli Dana Chief Financial Officer	C-Suite Officer	26 316 Value: $53.7K
Jul 16, 2025 Buy	Stock Option (right to buy) A-Award	Yaacov-garbeli Dana Chief Financial Officer	C-Suite Officer	130 000 Value: $296.4K
Jul 16, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Burshtein Gregory Chief Of R&d	Officer	26 316 Value: $53.7K
Jul 16, 2025 Buy	Stock Option (right to buy) A-Award	Burshtein Gregory Chief Of R&d	Officer	200 000 Value: $456.0K
Jul 16, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	136 842 Value: $279.2K
Jul 16, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	43 860 Value: $89.5K
Jul 16, 2025 Buy	Stock Option (Right to Buy) A-Award	Toledano Miranda Jayne Chief Executive Officer	CEO / President	500 000 Value: $1.14M
May 08, 2025 Buy	Stock Option (right to buy)	Gautam Leslie Velka Chief Business Officer	Officer	60 000 Value: $136.8K
May 08, 2025 Buy	Stock Option (right to buy)	Gautam Leslie Velka Chief Business Officer	Officer	60 000 Value: $136.8K
Apr 28, 2025 Buy	Stock Option (right to buy) A-Award	Galitzer Hillel Chief Operating Officer	C-Suite Officer	100 000 Value: $228.0K
Apr 28, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Galitzer Hillel Chief Operating Officer	C-Suite Officer	26 316 Value: $60.0K
Apr 28, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Galitzer Hillel Chief Operating Officer	C-Suite Officer	26 316 Value: $60.0K
Apr 28, 2025 Buy	Stock Option (right to buy) A-Award	Galitzer Hillel Chief Operating Officer	C-Suite Officer	100 000 Value: $228.0K
Apr 01, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share M-Exempt	Lieberman Gerald M Director	Director	23 952 Value: $24.0K
Apr 01, 2025 Buy	Warrant (right to buy) M-Exempt	Lieberman Gerald M Director	Director	23 952 Value: $24.0K
Apr 01, 2025 Buy	Warrant (right to buy) M-Exempt	Lieberman Gerald M Director	Director	23 952 Value: $24.0K
Apr 01, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share M-Exempt	Lieberman Gerald M Director	Director	23 952 Value: $24.0K
Jan 15, 2025 Buy	Stock Option (right to buy) A-Award	Ellis Sean Director	Director	28 509 Value: $65.0K
Jan 15, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Taitel Haya Director	Director	6 922 Value: $15.8K
Jan 15, 2025 Buy	Stock Option (right to buy) A-Award	Taitel Haya Director	Director	28 509 Value: $65.0K
Jan 15, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Ostrov Gerald M Director	Director	8 038 Value: $18.3K
Jan 15, 2025 Buy	Stock Option (right to buy) A-Award	Ostrov Gerald M Director	Director	28 509 Value: $65.0K
Jan 15, 2025 Buy	Ordinary Shares, par value NIS 0.0000769 per share A-Award	Malca Yonatan Director	Director	8 216 Value: $18.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ENTERA BIO LTD.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials fo...

Read Full Profile Here